Metagenomi Technologies, Llc share price logo

Metagenomi Technologies, Llc Share Price

NASDAQ: MGX

Small Cap

$1.31

-0.08

(-5.76%)

as on

Metagenomi Technologies, Llc Stock Performance

as on March 28, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.30
    $1.42
    downward going graph

    0.76%

    Downside

    8.40%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.23
    $3.95
    downward going graph

    6.11%

    Downside

    201.53%

    Upside

    downward going graph

Metagenomi Technologies, Llc share price movements today

Previous Close
$1.39
Open
$1.38
Volume
552.1K
Day's Low - High
$1.30 - $1.42
52 Week Low - High
$1.23 - $3.95

Metagenomi Technologies, Llc Historical Returns

1 Month Return
-13.16 %
3 Month Return
-22.35 %
1 Year Return
-10.81 %
3 Year Return
0 %
5 Year Return
0 %

Metagenomi Technologies, Llc Stock Fundamentals & Key Indicators

Check Metagenomi Technologies, Llc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$52.3M

EPS (TTM)

-2.3375

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-90.7M

Revenue (TTM)

25.2M

Profit Margin

0.00%

Return On Equity TTM

-44.67%

Metagenomi Technologies, Llc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Metagenomi Technologies, Llc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Metagenomi Technologies, Llc image
Metagenomi Technologies, Llc
BUY$52.3MNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$43.5B132.92%140.848.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.2B101.77%29.5832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.8BNA112.585.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$80.0B54.69%18.2531.41%

Stock Returns calculator for Metagenomi Technologies, Llc Stock including INR - Dollar returns

The Metagenomi Technologies, Llc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Metagenomi Technologies, Llc investment value today

Current value as on today

₹98,011

Returns

-₹1,989

(-1.99%)

Returns from Metagenomi Technologies, Llc Stock

-₹11,486 (-11.49%)

Dollar Impact

₹9,498 (+9.5%)

Analyst Recommendation on Metagenomi Technologies, Llc Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Metagenomi Technologies, Llc. Average target price of $9.33

Metagenomi Technologies, Llc Share Price Target

Get share price movements and forecasts by analysts on Metagenomi Technologies, Llc.

What analysts predicted

85.96%UPSIDE

Target Price

$9.33

Current Price

$1.31

Analyzed by

10 Analysts

Target

$9.33

Metagenomi Technologies, Llc target price $9.33, a slight upside of 85.96% compared to current price of $1.31. According to 10 analysts rating.

Metagenomi Technologies, Llc Stock’s Investor Sentiment and Interest

Search interest for Metagenomi Technologies, Llc Stock has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-31% versus previous 30 day period

Metagenomi Technologies, Llc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
12
12
11
20
11
9
4
8
8
3
Gross Profit
-14
-12
-20
20
11
9
4
-13
7
2
Operating Income
-22
-20
-29
-16
-22
-20
-27
-20
-22
-24
EBITDA
-21
-18
-27
-15
-21
-19
-26
-19
-19
-23
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
1
1
1
1
1
1
1
1
1
1
Income Before Tax
-18
-16
-25
-12
-20
-24
-24
-19
-20
-22
Income Tax Expense
1
2
-3
-2
-2
-1
0
0
0
0
Net Income
-19
-19
-25
-10
-18
-23
-25
-19
-20
-22
Net Profit Margin
-160.32%
-155.61%
-225.36%
-53.67%
-163.04%
-243.37%
-606.71%
-233.85%
-235.51%
-576.02%

Metagenomi Technologies, Llc Annual Profit & Loss

All numbers in Millions USD

Sep 2021
Sep 2022
Sep 2023
Sep 2024
Sep 2025
Total Revenue
0
17
44
52
25
Gross Profit
0
15
-49
52
19
Operating Income
-23
-44
-78
-88
-96
EBITDA
-20
-39
-74
-83
-90
Interest Expense
0
0
-
-
-
Depreciation
0
1
4
5
5
Income Before Tax
-21
-41
-60
-83
-87
Income Tax Expense
0
2
8
-5
0
Net Income
-21
-43
-68
-78
-87
Net Profit Margin
-8823.87%
-253.45%
-152.50%
-149.26%
-348.54%

Metagenomi Technologies, Llc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-19
-25
-10
-18
-23
-25
-19
-20
-22
Operating Cash Flow
-20
-29
-26
-26
-26
-22
-21
-21
-23
Investing Cash Flow
60
-94
-13
-8
28
24
19
27
32
Financing Cash Flow
-1
86
-2
0
-
0
0
0
0
Change in Cash
38
-38
-41
-36
2
1
-2
5
8

Metagenomi Technologies, Llc Annual Cash Flow

All numbers in Millions USD

Sep 2022
Sep 2023
Sep 2024
Sep 2025
Net Income
-43
-68
-78
-87
Operating Cash Flow
29
-91
-109
-88
Investing Cash Flow
-122
45
-88
103
Financing Cash Flow
239
1
84
0
Change in Cash
147
-44
-113
14

Insights on Metagenomi Technologies, Llc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 18.2% return, outperforming this stock by 29.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, MGX stock has moved down by -7.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -19.90M → -22.52M (in $), with an average decrease of 6.5% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 8.65M → 3.91M (in $), with an average decrease of 54.8% per quarter

About Metagenomi Technologies, Llc

Metagenomi Therapeutics, Inc. is an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients. It is developed to discover and develop a suite of novel editing tools potentially capable of correcting any type of genetic mutation found anywhere in the human genome. It focuses on high value programs in disease indications with well-understood biology and clearly defined clinical development and regulatory pathways. MGX-001, its lead, wholly owned development program in hemophilia A, has demonstrated a preclinical profile potentially competitive with treatment options, including targeted genome editing and durable gene expression in a one-time treatment. MGX-001 is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia A. MGX-001 is designed to insert a Factor VIII (FVIII) DNA cassette into a safe harbor location within an intron of the albumin gene.
OrganisationMetagenomi Technologies, Llc
Headquarters5959 Horton Street, Emeryville, CA, United States, 94608
CEODr. Jian Irish M.B.A., Ph.D.
E-voting on sharesClick here to vote

Key Management of Metagenomi Technologies, Llc

Name

Title

Ms. Katalin Kauser M.D., Ph.D.

Senior Vice Pres­i­dent of Trans­la­tion­al Biol­o­gy

Dr. Jian Irish M.B.A., Ph.D.

CEO, President & Director

Dr. Brian Charles Thomas Ph.D.

Co-Founder & Director

Ms. Pamela M. Wapnick M.B.A.

Chief Financial Officer

Dr. Joseph Knowles M.D.

Co-Founder & Member of Scientific Advisory Board

Mr. Mark Leonard

Senior Vice Pres­i­dent of Tech­ni­cal Devel­op­ment & Oper­a­tions

Mr. Matthew L. Wein J.D.

Gen­er­al Coun­sel, Com­pli­ance Offi­cer, Head of BD&L and Cor­po­rate Secretary

Dr. Alan Brooks Ph.D.

Senior Vice President of Research

FAQs

What is Metagenomi Technologies, Llc share price today?

Metagenomi Technologies, Llc share price today is $1.31 as on at the close of the market. Metagenomi Technologies, Llc share today touched a day high of $1.42 and a low of $1.3.

What is the 52 week high and 52 week low for Metagenomi Technologies, Llc share?

Metagenomi Technologies, Llc share touched a 52 week high of $3.95 on and a 52 week low of $1.23 on . Metagenomi Technologies, Llc stock price today i.e. is closed at $1.31,which is 66.84% down from its 52 week high and 6.50% up from its 52 week low.

What is Metagenomi Technologies, Llc's market capitalisation today?

Metagenomi Technologies, Llc market capitalisation is $0.00T as on .

How to invest in Metagenomi Technologies, Llc Stock (MGX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Metagenomi Technologies, Llc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Metagenomi Technologies, Llc Shares that will get you 1.1450 shares as per Metagenomi Technologies, Llc share price of $1.31 per share as on March 28, 2026 at 1:29 am IST.

What is the minimum amount required to buy Metagenomi Technologies, Llc Stock (MGX) from India?

Indian investors can start investing in Metagenomi Technologies, Llc (MGX) shares with as little as ₹94.63 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.30 in Metagenomi Technologies, Llc stock (as per the Rupee-Dollar exchange rate as on ). Based on Metagenomi Technologies, Llc share’s latest price of $1.31 as on March 28, 2026 at 1:29 am IST, you will get 7.6336 shares of Metagenomi Technologies, Llc. Learn more about fractional shares .